Home

vastaaineita

Vasta-aineita (antibodies) are Y-shaped glycoproteins of the adaptive immune system produced mainly by plasma cells derived from B lymphocytes. They recognize specific antigens—foreign molecules such as proteins on pathogens or toxins—and bind them with high specificity. Each antibody consists of two identical heavy chains and two identical light chains, forming Fab (antigen-binding) fragments and an Fc (crystallizable) fragment. The variable regions confer antigen specificity, while the constant regions define the immunoglobulin class (IgG, IgM, IgA, IgD, IgE). Immunoglobulin diversity arises through gene rearrangement (V(D)J recombination), followed by somatic hypermutation and class-switch recombination during immune responses.

Antibodies participate in multiple effector mechanisms: neutralization of toxins and viruses, agglutination and precipitation of antigens,

Clinically, antibodies are used in diagnostics (serology tests such as ELISA and Western blot) and therapeutics

opsonization
to
enhance
phagocytosis,
activation
of
the
classical
complement
pathway,
and
antibody-dependent
cellular
cytotoxicity.
They
also
form
the
basis
of
immunological
memory,
enabling
rapid
and
robust
responses
upon
re-exposure
to
the
same
antigen.
(monoclonal
antibodies
for
cancer,
autoimmune
diseases,
and
infections).
Vaccines
aim
to
elicit
protective
antibody
responses.
The
structure
and
function
of
antibodies
were
elucidated
in
the
20th
century,
with
Gerald
Edelman
and
Rodney
Porter
awarded
the
Nobel
Prize
in
Physiology
or
Medicine
in
1972
for
discoveries
concerning
the
structure
of
antibodies.